Exagen Inc. Announces Study on the Long-Term Effects of COVID-19 Infection in the Development of Autoimmune Diseases
March 29, 2021 08:25 ET
|
Exagen Inc.
SAN DIEGO, March 29, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today...
Exagen, Maker of AVISE Testing, Announces First Blood Test for Anti-CarP, a Breakthrough Bio-marker for Rheumatoid Arthritis
September 11, 2018 10:05 ET
|
Exagen Diagnostics, Inc.
San Diego, CA and Albuquerque, NM, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Exagen Diagnostics, the leader in specialty rheumatology testing, announced today availability of the first validated blood test...